Business Insights
Diagnostic Technologies
Diseases
Point-of-Care Testing
Research & Development
Sign In
Clinical Trials
Collaboration
Funding
Funding
Lumos gets $3M in from BARDA to support POC test submission
By
LabPulse.com staff writers
Lumos has been awarded approximately $3 million from BARDA in support of the clinical study and regulatory submission for the company’s bacterial/nonbacterial point-of-care (POC) respiratory infection test.
October 7, 2024
NIH establishes pandemic preparedness research network
By
LabPulse.com staff writers
The U.S. National Institutes of Health (NIH) has established a pandemic preparedness research network for research on the pathogens that are most likely to threaten human health.
September 19, 2024
Mount Sinai Health gets $3.26M NIH grant for undiagnosed diseases center
By
LabPulse.com staff writers
Mount Sinai Health received a four-year, $3.26 million grant from the U.S. National Institutes of Health (NIH) to establish the new Mount Sinai Center for Undiagnosed Diseases, the first Undiagnosed Diseases Network site in the New York metropolitan area.
September 17, 2024
HudsonAlpha Institute gets $2.9M NIH grant for pediatric rare disease sequencing
By
LabPulse.com staff writers
Scientists at the HudsonAlpha Institute for Biotechnology in Huntsville, AL, have been awarded a five-year, $2.9 million U.S. National Institutes of Health (NIH) grant to identify genetic contributors to rare diseases in children.
September 6, 2024
Seegene, Springer Nature launch PCR innovation program
By
LabPulse.com staff writers
Molecular diagnostics firm Seegene and Springer Nature have launched a new project for the development of diagnostic assays, as part of their ongoing strategic partnership.
September 3, 2024
Alpenglow Biosciences lands $24M for 3D pathology platform
By
LabPulse.com staff writers
Company gets boost to commercialize direct-to-digital pathology platform and AI.
August 15, 2024
Leuko receives $4.5M SBIR grant for blood monitoring device
By
LabPulse.com staff writers
Medtech firm Leuko has received a $4.5 million award from the U.S. National Institutes of Health National Cancer Institute to advance the development of PointCheck, its noninvasive at-home white blood cell monitoring device.
July 24, 2024
Tiba Biotech awarded BARDA contract for influenza therapeutics
By
LabPulse.com staff writers
Tiba Biotech has been awarded an Easy Broad Agency Announcement R&D contract through the Biomedical Advanced Research and Development Authority (BARDA) to develop therapeutics against influenza.
July 12, 2024
BARDA awards Moderna $176M for pandemic flu vaccine development
By
LabPulse.com staff writers
The Biomedical Advanced Research and Development Authority (BARDA) has awarded Moderna approximately $176 million for the development of an mRNA-based pandemic influenza vaccine.
July 2, 2024
GMU researchers receive $1.2M in funding for Lyme disease urine test
By
LabPulse.com staff writers
Researchers at George Mason University (GMU) have received $1.2 million in federal funding from the U.S. Department of the Army to develop a urine-based test for the detection and diagnosis of Lyme disease.
May 24, 2024
Nanopath awarded $4M in SBIR grants
By
LabPulse.com staff writers
Nanopath has announced that it has been awarded two grants worth a total of $4 million in federal funding through the Small Business Innovation Research (SBIR) program.
May 22, 2024
AMDI receives $5.2M in RADx Tech funding for PCR viral testing system
By
LabPulse.com staff writers
Autonomous Medical Devices Incorporated (AMDI) has received a U.S. National Institutes of Health (NIH) RADx Tech award of up to $5.2 million to finalize its rapid point-of-care viral testing system.
March 4, 2024
Page 1 of 5
Next Page